science
Former FDA Commissioner Says Acting Head Can Stabilize Agency
Former FDA commissioner David Kessler said acting commissioner Kyle Diamantas has the background to bring stability to the agency during a period of leadership changes. Kessler spoke at the STAT Breakthrough Summit West in San Francisco on Tuesday.
May 19, 1:16 PM·1m read1 source
prnewswire.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Former FDA commissioner David Kessler said the agency’s acting commissioner can provide stability after recent leadership turnover. Kessler spoke at STAT’s Breakthrough Summit West in San Francisco on Tuesday. He said Kyle Diamantas understands agency processes despite not being a physician.
Administration has seen several high-profile departures in recent months. Kessler described the current period as an opportunity for the agency to improve operations. Diamantas, an attorney, was appointed acting commissioner following those exits. Kessler told the audience he has “great confidence” in Diamantas.
Kessler served as FDA commissioner from 1990 to 1997. He said Diamantas can serve as a stabilizing force for staff and regulatory work.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
